
USANA Health Sciences, Inc.
USANA Health Sciences, Inc.(USNA)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
usna · 股价预测 · 8 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$35.00
Consensus
$35.00
+91.4% upside
Low
$35.00
Median: $35 · Last Close: $18.29
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $18.22 | ↓ 0.40% |
1-day model range: $18.12–$18.31. Peak: $18.31 (-0.40%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $13 | -30.5% |
| 2028 | $11 | -42.2% |
| 2029 | $10 | -47.6% |
| 2030 | $9 | -50.2% |
| 2031 | — | -51.6% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · USNA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-02-27 | DA Davidson | Maintains | Neutral→Neutral |
| 2025-01-02 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-10-23 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-07-25 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-05-07 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-02-22 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-10-25 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-04-26 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-02-13 | DA Davidson | Maintains | Neutral→Neutral |
| 2022-10-27 | DA Davidson | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on USANA Health Sciences, Inc. (USNA) stock. Of the recent 40 rating actions, 5 were upgrades and 10 were downgrades. 8 analysts currently cover USNA.
分析师推荐趋势
USNA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$875M
↓ 5.4% YoY
Revenue Next Year
$850M
↓ 2.9% YoY
EPS This Year
$2.87
EPS Next Year
$2.45
↓ 14.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast USNA EPS of $2.87 for the current fiscal year, based on estimates from 1 analysts. The USNA revenue forecast is $875M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
USNA 股价预测由两类独立数据源支撑:来自 8 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。USNA 的共识目标价为 $35.00(+91.4% 上行空间),分析师共识为 Hold。
USNA 的短期预测(明日)为 $18.22(-0.40%)。 USNA 对 2027 年的股价预测均值为 $13。 USNA 对 2030 年的预测区间为 $9–$10。
USANA Health Sciences, Inc. 在 NYSE 上市,代码 USNA。USNA 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 25% 对应 Hold 共识。
常见问题
USNA 预测 · 8 个问题根据 8 位华尔街分析师,USNA 的 12 个月平均目标价为 $35.00,最高 $35.00、最低 $35.00。若有图表,中位目标价可在上方查看。相对当前价 $18.29,隐含约 +91.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.